BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Contino M, Guglielmo S, Riganti C, Antonello G, Perrone MG, Giampietro R, Rolando B, Fruttero R, Colabufo NA. One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells. European Journal of Medicinal Chemistry 2020;208:112843. [DOI: 10.1016/j.ejmech.2020.112843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Feyzizadeh M, Barfar A, Nouri Z, Sarfraz M, Zakeri-Milani P, Valizadeh H. Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery. Expert Opin Drug Discov 2022;:1-15. [PMID: 35996765 DOI: 10.1080/17460441.2022.2112666] [Reference Citation Analysis]
2 Val C, Rodríguez-garcía C, Prieto-díaz R, Crespo A, Azuaje J, Carbajales C, Majellaro M, Díaz-holguín A, Brea JM, Loza MI, Gioé-gallo C, Contino M, Stefanachi A, García-mera X, Estévez JC, Gutiérrez-de-terán H, Sotelo E. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A 1 Antagonists. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01636] [Reference Citation Analysis]
3 Sohail M, Sun Z, Li Y, Gu X, Xu H. Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy. Expert Rev Anticancer Ther 2021;21:1385-98. [PMID: 34636282 DOI: 10.1080/14737140.2021.1991316] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Farahani MV, Hushmandi K, Zarrabi A, Goldman A, Ashrafizadeh M, Orive G. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discov Today 2021:S1359-6446(21)00428-1. [PMID: 34624510 DOI: 10.1016/j.drudis.2021.09.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
5 Laiolo J, Lanza PA, Parravicini O, Barbieri C, Insuasty D, Cobo J, Vera DMA, Enriz RD, Carpinella MC. Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp. Sci Rep 2021;11:16856. [PMID: 34413359 DOI: 10.1038/s41598-021-96226-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Qiu Q, Zou F, Li H, Shi W, Zhou D, Zhang P, Li T, Yin Z, Cai Z, Jiang Y, Huang W, Qian H. Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance. J Med Chem 2021;64:6179-97. [PMID: 33938746 DOI: 10.1021/acs.jmedchem.1c00246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]